½ÃÀ庸°í¼­
»óǰÄÚµå
1457998

¼¼°èÀÇ À¯µ¿¼º ÁöÇ÷Á¦ ½ÃÀå Á¶»ç º¸°í¼­ : »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ ¹× ¿¹Ãø(2024-2032³â)

Global Flowable Hemostats Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Value Market Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 235 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

À¯µ¿¼º ÁöÇ÷Á¦ÀÇ ¼¼°è ¼ö¿ä´Â 2023³â 7¾ï 6,278¸¸ ´Þ·¯¿¡¼­ 2032³â¿¡´Â 12¾ï 9,417¸¸ ´Þ·¯ ±Ùó ½ÃÀå ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µÇ¸ç, Á¶»ç ±â°£ 2024-2032³âÀÇ CAGRÀº 6.05%¿¡ À̸¦ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù.

À¯µ¿¼º ÁöÇ÷Á¦´Â ¼ö¼ú ¹× ¿Ü»ó½Ã ÃâÇ÷À» ¾ïÁ¦Çϵµ·Ï ¼³°èµÈ ÀÇ·á¿ë ¹°ÁúÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¾à¹°Àº ÀϹÝÀûÀ¸·Î ¾×ü ¶Ç´Â °Ö ÇüÅÂÀ̸ç ÃâÇ÷ ºÎÀ§¿¡ ½±°Ô Àû¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ÁöÇ÷Á¦´Â Ç÷¾× ÀÀ°í¸¦ ÃËÁøÇÏ°í »óó Ä¡À¯¸¦ °¡¼ÓÈ­Çϱâ À§ÇØ ÀÇ·á ÇöÀå¿¡¼­ ÃâÇ÷À» È¿°úÀûÀ¸·Î °ü¸®ÇÏ´Â ±ÍÁßÇÑ µµ±¸ÀÔ´Ï´Ù.

½ÃÀå ¿ªÇÐ

À¯µ¿¼º ÁöÇ÷Á¦ ½ÃÀåÀº ¼¼°è ¿Ü°ú ¼ö¼ú °Ç¼ö Áõ°¡¿Í ÃâÇ÷¼º ÁúȯÀÇ À¯º´·ü »ó½Â¿¡ °ßÀÎµÇ¾î °­·ÂÇÑ ¼ºÀåÀ» ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ÁöÇ÷Á¦´Â ³·Àº ħ½À ¼ö¼ú¿¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» Çϱ⠶§¹®¿¡ ÀαⰡ ³ô¾ÆÁö°í ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á±â¼ú°ú ¼ö¼úÀÇ Áøº¸°¡ Å©°Ô ±â¿©Çϰí È¿°úÀûÀÎ ÁöÇ÷ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ âÃâµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª Á¦Ç° ½ÂÀÎÀ» À§ÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°ÇÀÌ °úÁ¦°¡ µÇ°í ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀÇ ºñ¿ë È¿°ú¿¡ ´ëÇÑ ¿ì·Á°¡ À¯µ¿¼º ÁöÇ÷Á¦ ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¾ïÁ¦¿äÀο¡µµ ºÒ±¸Çϰí À¯µ¿¼º ÁöÇ÷Á¦ ½ÃÀåÀº ÀÌ·¯ÇÑ ÀúÇØ ¿äÀÎÀ» ÇØ°áÇϰí È¿À²ÀûÀÎ ÁöÇ÷ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ Áö¼ÓÀûÀÎ R&D ³ë·ÂÀ» ÅëÇØ ÁøÈ­¸¦ °è¼Ó ÀÖ½À´Ï´Ù.

ÀÌ ¼³¹® Á¶»ç º¸°í¼­´Â Porter's Five Forces ¸ðµ¨, ½ÃÀå ¸Å·Â ºÐ¼®, ¹ë·ùüÀÎ ºÐ¼®À» ´Ù·ì´Ï´Ù. ÀÌ·¯ÇÑ µµ±¸´Â ¾÷°èÀÇ ±¸Á¶¸¦ ¸íÈ®ÇÏ°Ô ÆÄ¾ÇÇÏ°í ¼¼°è ¼öÁØ¿¡¼­ °æÀïÀÇ ¸Å·ÂÀ» Æò°¡ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¶ÇÇÑ, ÀÌ·¯ÇÑ µµ±¸´Â À¯µ¿¼º ÁöÇ÷Á¦ ¼¼°è ½ÃÀå¿¡¼­ °¢ ºÎ¹®À» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. À¯µ¿¼º ÁöÇ÷Á¦ »ê¾÷ÀÇ ¼ºÀå°ú µ¿ÇâÀº ÀÌ ¿¬±¸¿¡ Àü¹ÝÀûÀÎ Á¢±ÙÀ» Á¦°øÇÕ´Ï´Ù.

½ÃÀå ¼¼ºÐÈ­

½ÃÀå ¼¼ºÐÈ­´Â ±¹°¡º° ¹× Áö¿ªº° ºÎ¹®¿¡ ´ëÇÑ »ó¼¼ÇÑ µ¥ÀÌÅ͸¦ Á¦°øÇÏ¿© °¢ Á¦Ç° ¼­ºñ½ºÀÇ ´ë»ó °èÃþÀ» ÆÄ¾ÇÇϰí ÇâÈÄ ºñÁî´Ï½º ±âȸ·Î À̾îÁú °ÍÀÔ´Ï´Ù.

Àç·áº°

  • µÅÁö Á©¶óƾ
  • ¼Ò Á©¶óƾ

¿ëµµº°

  • ÀÏ¹Ý ¿Ü°ú
  • ½ÉÀå¿Ü°ú
  • Ç÷°ü ¼ö¼ú
  • ½Å°æ ¹× ôÃ߿ܰú
  • Á¤Çü¿Ü°ú
  • ±âŸ

ÃÖÁ¾ »ç¿ëÀÚº°

  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð

Áö¿ªº° ºÐ¼®

ÀÌ ¼½¼Ç¿¡¼­´Â ºÏ¹Ì, À¯·´, ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä« ¹× Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«¿¡¼­ À¯µ¿¼º ÁöÇ÷Á¦ ½ÃÀåÀÇ ÇöÀç ¹× ¹Ì·¡ ¼ö¿ä¸¦ °­Á¶ÇÏ´Â Áö¿ª Àü¸ÁÀ» ´Ù·ì´Ï´Ù. ¶ÇÇÑ, Àú¸íÇÑ ¸ðµç Áö¿ª¿¡¼­ÀÇ °³º° ¿ëµµ ºÎ¹® ¼ö¿ä¡¤ÃßÁ¤¡¤¿¹Ãø¿¡µµ ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù.

  • À¯µ¿¼º ÁöÇ÷Á¦ÀÇ ¼¼°èÀÇ Áö¿ªº° ½ÃÀå Á¡À¯À²(´ëÇ¥ ±×·¡ÇÁ)
  • À¯µ¿¼º ÁöÇ÷Á¦ ¼¼°è ½ÃÀå Á¡À¯À²

Ä¿½ºÅÒ ¸ÞÀ̵åÀÇ ¿ä±¸°¡ ÀÖÀ¸¸é, ÀúÈñ¿¡°Ô ¿¬¶ôÇØ ÁÖ¼¼¿ä. ´ç»çÀÇ Á¶»ç ÆÀÀº °í°´ÀÇ ¿ä±¸¿¡ µû¶ó ¸ÂÃãÇü º¸°í¼­¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀåÀÇ ÇÏÀ̶óÀÌÆ®
  • ¼¼°è ½ÃÀå ÇöȲ

Á¦3Àå À¯µ¿¼º ÁöÇ÷Á¦ÀÇ »ê¾÷ ºÐ¼®

  • ¼Ò°³: ½ÃÀå ¿ªÇÐ
  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ½ÃÀå ±âȸ
  • ¾÷°è µ¿Çâ
  • Porter's Five Forces ºÐ¼®
  • ½ÃÀå ¸Å·Âµµ ºÐ¼®

Á¦4Àå ¹ë·ùüÀÎ ºÐ¼®

  • ¹ë·ùüÀÎ ºÐ¼®
  • ¿øÀç·á ºÐ¼®
    • ¿øÀç·á ¸®½ºÆ®
    • ¿øÀç·á Á¦Á¶¾÷ü ¸®½ºÆ®
    • ÁÖ¿ä ¿øÀç·áÀÇ °¡°Ý µ¿Çâ
  • ÀáÀçÀû ¹ÙÀ̾î À϶÷
  • ¸¶ÄÉÆÃ Ã¤³Î
    • Á÷Á¢ ¸¶ÄÉÆÃ
    • °£Á¢ ¸¶ÄÉÆÃ
    • ¸¶ÄÉÆÃ Ã¤³Î ¹ßÀü µ¿Çâ

Á¦5Àå À¯µ¿¼º ÁöÇ÷Á¦ ¼¼°è ½ÃÀå ºÐ¼® : Àç·áº°

  • Àç·áº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • Àç·áº° ºÐ¼®
  • µÅÁö Á©¶óƾ
  • ¼Ò Á©¶óƾ

Á¦6Àå À¯µ¿¼º ÁöÇ÷Á¦ ¼¼°è ½ÃÀå ºÐ¼® : ¿ëµµº°

  • ¿ëµµº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ¿ëµµº° ºÐ¼®
  • ÀÏ¹Ý ¿Ü°ú
  • ½ÉÀå¿Ü°ú
  • Ç÷°ü ¼ö¼ú
  • ½Å°æ ¹× ôÃ߿ܰú
  • Á¤Çü¿Ü°ú
  • ±âŸ

Á¦7Àå À¯µ¿¼º ÁöÇ÷Á¦ ¼¼°è ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

  • ÃÖÁ¾ »ç¿ëÀÚº° °³¿ä
  • ½ÇÀû µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅÍ
  • ÃÖÁ¾ »ç¿ëÀÚº° ºÐ¼®
  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð

Á¦8Àå À¯µ¿¼º ÁöÇ÷Á¦ ¼¼°è ½ÃÀå ºÐ¼® : Áö¿ªº°

  • Áö¿ªº° Àü¸Á
  • ¼Ò°³
  • ºÏ¹Ì ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ºÏ¹Ì : ºÎ¹®º°
    • ºÏ¹Ì : ±¹°¡º°
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´ ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • À¯·´ : ºÎ¹®º°
    • À¯·´ : ±¹°¡º°
    • ¿µ±¹
    • ÇÁ¶û½º
    • µ¶ÀÏ
    • ÀÌÅ»¸®¾Æ
    • ·¯½Ã¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ºÎ¹®º°
    • ¾Æ½Ã¾ÆÅÂÆò¾ç : ±¹°¡º°
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • Çѱ¹
    • È£ÁÖ
    • µ¿³²¾Æ½Ã¾Æ
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • ¶óƾ¾Æ¸Þ¸®Ä« : ºÎ¹®º°
    • ¶óƾ¾Æ¸Þ¸®Ä« : ±¹°¡º°
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
    • Æä·ç
    • Ä¥·¹
    • ±âŸ ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¸ÅÃ⠺м®
    • °³¿ä, ½ÇÀû°ú ¿¹Ãø
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ºÎ¹®º°
    • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« : ±¹°¡º°
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • À̽º¶ó¿¤
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå À¯µ¿¼º ÁöÇ÷Á¦°æÀï ±¸µµ

  • À¯µ¿¼º ÁöÇ÷Á¦ ½ÃÀå °æÀï
  • Á¦ÈÞ, Çù·Â, °è¾à
  • ÇÕº´ ¹× Àμö
  • ½ÅÁ¦Ç° Ãâ½Ã
  • ±âŸ °³¹ß

Á¦10Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • ±â¾÷ Á¡À¯À² ºÐ¼®
  • ½ÃÀå ÁýÁßµµ
  • Johnson & Johnson
  • Baxter International Inc.
  • Teleflex Incorporated
JHS 24.04.09

The global demand for Flowable Hemostats Market is presumed to reach the market size of nearly USD 1294.17 Million by 2032 from USD 762.78 Million in 2023 with a CAGR of 6.05% under the study period 2024 - 2032.

Flowable hemostats are medical substances designed to control bleeding during surgeries or traumatic injuries. These agents are typically liquid or gel, allowing for easy application to bleeding sites. These hemostats promote blood clotting and facilitate faster wound healing, making them valuable tools in medical settings to manage hemorrhage effectively.

MARKET DYNAMICS

The flowable hemostats market experiences robust growth driven by the increasing number of surgical procedures globally and the rising prevalence of bleeding disorders. These hemostats' critical role in minimally invasive surgeries enhances their popularity, contributing to market expansion. Medical technology and surgical practice advancements contribute significantly, creating a demand for effective hemostatic solutions. However, stringent regulatory requirements for product approval pose challenges, and concerns regarding the cost-effectiveness of these solutions may impede flowable hemostats' market growth. Despite these hurdles, the flowable hemostats market continues to evolve, driven by ongoing research & development efforts to address these restraints and meet the growing demand for efficient hemostatic solutions.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of flowable hemostats. The growth and trends of flowable hemostats industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the flowable hemostats market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Material

  • Porcine Gelatin
  • Bovine Gelatin

By Application

  • General Surgery
  • Cardiac Surgery
  • Vascular Surgery
  • Neuro & Spine Surgery
  • Orthopedic Surgery
  • Others

By End-User

  • Hospitals
  • Ambulatory Surgery Centers
  • Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Flowable Hemostats market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

  • GLOBAL FLOWABLE HEMOSTATS MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
  • Global Flowable Hemostats Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Flowable Hemostats market include Johnson & Johnson, Baxter International, Inc., Teleflex Incorporated. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . FLOWABLE HEMOSTATS - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Material
    • 3.7.2 Market Attractiveness Analysis By Application
    • 3.7.3 Market Attractiveness Analysis By End-User
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL FLOWABLE HEMOSTATS MARKET ANALYSIS BY MATERIAL

  • 5.1 Overview by Material
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Material
  • 5.4 Porcine Gelatin Historic and Forecast Sales by Regions
  • 5.5 Bovine Gelatin Historic and Forecast Sales by Regions

6 . GLOBAL FLOWABLE HEMOSTATS MARKET ANALYSIS BY APPLICATION

  • 6.1 Overview by Application
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Application
  • 6.4 General Surgery Historic and Forecast Sales by Regions
  • 6.5 Cardiac Surgery Historic and Forecast Sales by Regions
  • 6.6 Vascular Surgery Historic and Forecast Sales by Regions
  • 6.7 Neuro & Spine Surgery Historic and Forecast Sales by Regions
  • 6.8 Orthopedic Surgery Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL FLOWABLE HEMOSTATS MARKET ANALYSIS BY END-USER

  • 7.1 Overview by End-User
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by End-User
  • 7.4 Hospitals Historic and Forecast Sales by Regions
  • 7.5 Ambulatory Surgery Centers Historic and Forecast Sales by Regions
  • 7.6 Clinics Historic and Forecast Sales by Regions

8 . GLOBAL FLOWABLE HEMOSTATS MARKET ANALYSIS BY GEOGRAPHY

  • 8.1. Regional Outlook
  • 8.2. Introduction
  • 8.3. North America Sales Analysis
    • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.3.2. North America By Segment Sales Analysis
    • 8.3.3. North America By Country Sales Analysis
    • 8.3.4. United State Sales Analysis
    • 8.3.5. Canada Sales Analysis
    • 8.3.6. Mexico Sales Analysis
  • 8.4. Europe Sales Analysis
    • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.4.2. Europe by Segment Sales Analysis
    • 8.4.3. Europe by Country Sales Analysis
    • 8.4.4. United Kingdom Sales Analysis
    • 8.4.5. France Sales Analysis
    • 8.4.6. Germany Sales Analysis
    • 8.4.7. Italy Sales Analysis
    • 8.4.8. Russia Sales Analysis
    • 8.4.9. Rest Of Europe Sales Analysis
  • 8.5. Asia Pacific Sales Analysis
    • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.5.2. Asia Pacific by Segment Sales Analysis
    • 8.5.3. Asia Pacific by Country Sales Analysis
    • 8.5.4. China Sales Analysis
    • 8.5.5. India Sales Analysis
    • 8.5.6. Japan Sales Analysis
    • 8.5.7. South Korea Sales Analysis
    • 8.5.8. Australia Sales Analysis
    • 8.5.9. South East Asia Sales Analysis
    • 8.5.10. Rest Of Asia Pacific Sales Analysis
  • 8.6. Latin America Sales Analysis
    • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.6.2. Latin America by Segment Sales Analysis
    • 8.6.3. Latin America by Country Sales Analysis
    • 8.6.4. Brazil Sales Analysis
    • 8.6.5. Argentina Sales Analysis
    • 8.6.6. Peru Sales Analysis
    • 8.6.7. Chile Sales Analysis
    • 8.6.8. Rest of Latin America Sales Analysis
  • 8.7. Middle East & Africa Sales Analysis
    • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 8.7.2. Middle East & Africa by Segment Sales Analysis
    • 8.7.3. Middle East & Africa by Country Sales Analysis
    • 8.7.4. Saudi Arabia Sales Analysis
    • 8.7.5. UAE Sales Analysis
    • 8.7.6. Israel Sales Analysis
    • 8.7.7. South Africa Sales Analysis
    • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE FLOWABLE HEMOSTATS COMPANIES

  • 9.1. Flowable Hemostats Market Competition
  • 9.2. Partnership/Collaboration/Agreement
  • 9.3. Merger And Acquisitions
  • 9.4. New Product Launch
  • 9.5. Other Developments

10 . COMPANY PROFILES OF FLOWABLE HEMOSTATS INDUSTRY

  • 10.1. Company Share Analysis
  • 10.2. Market Concentration Rate
  • 10.3. Johnson & Johnson
    • 10.3.1. Company Overview
    • 10.3.2. Company Revenue
    • 10.3.3. Products
    • 10.3.4. Recent Developments
  • 10.4. Baxter International Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Company Revenue
    • 10.4.3. Products
    • 10.4.4. Recent Developments
  • 10.5. Teleflex Incorporated
    • 10.5.1. Company Overview
    • 10.5.2. Company Revenue
    • 10.5.3. Products
    • 10.5.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦